Synopsis
Synopsis
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ca Lactate
1. 814-80-2
2. Calcium Dilactate
3. Calphosan
4. Hemicalcium L-lactate
5. Lactic Acid, Calcium Salt (2:1)
6. Calcium;2-hydroxypropanoate
7. Calcium 2-hydroxypropanoate
8. Propanoic Acid, 2-hydroxy-, Calcium Salt (2:1)
9. 2-hydroxypropanoic Acid Calcium Salt
10. 5743-48-6
11. Calcium Lactate Anhydrous
12. Calcium 2-hydroxypropanoate (1:2)
13. 63690-56-2
14. Calcium (as Lactate)
15. Calcium Bis(2-hydroxypropanoate)
16. Calcium Lactate, Anhydrous
17. Ins No.327
18. 28305-25-1
19. 2urq2n32w3
20. Ins-327
21. Ins-327-
22. Dsstox_cid_236
23. Conclyte Calcium
24. E-327
25. Dsstox_rid_75451
26. Dsstox_gsid_20236
27. Ca Lactate
28. Cas-814-80-2
29. Calcium Lactate [usan:jan]
30. Ccris 3669
31. Hsdb 976
32. Einecs 212-406-7
33. Unii-2urq2n32w3
34. Ai3-04468
35. Calcium Dl-lactate
36. Einecs 227-266-2
37. Calcium Lactate [ii]
38. Calcium Lactate [mi]
39. Calcium Lactate [fcc]
40. Calcium Lactate [hsdb]
41. Calcium Lactate [inci]
42. Calcium Lactate (1:2)
43. Calcium Lactate [vandf]
44. Ec 212-406-7
45. Calcium Lactate [who-dd]
46. Schembl4319
47. Calcium (as Lactate) [vandf]
48. Chembl2106111
49. Dtxsid0020236
50. Hy-b2227a
51. Calcium Lactate [usp-rs]
52. Lactic Acid Calcium Salt (2:1)
53. Amy37027
54. Tox21_201378
55. Tox21_302896
56. Bis(2-hydroxypropanoic Acid) Calcium
57. Mfcd00035548
58. Akos015837558
59. Calcium Lactate [ep Monograph]
60. Db13231
61. Ncgc00256365-01
62. Ncgc00258929-01
63. (+/-)-lactic Acid, Calcium Salt (2:1)
64. Db-023012
65. Cs-0021602
66. Ft-0623403
67. Ft-0652809
68. F16480
69. Calcium Lactate Anhydrous [usp Monograph]
70. Calcium Lactate, Anhydrous [ep Impurity]
71. A840142
72. Q419693
73. L(+) Lactic Acid Calcium Salt Pentahydr. 98%, Fcc
Molecular Weight | 218.22 g/mol |
---|---|
Molecular Formula | C6H10CaO6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 218.0103289 g/mol |
Monoisotopic Mass | 218.0103289 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 53.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
EXPTL USE: ORAL ADMIN OF CALCIUM LACTATE (7.7 G) LOWERED PLASMA PARATHYROID HORMONE BY 40-43% & DECR URINARY EXCRETION OF CYCLIC ADENOSINE MONOPHOSPHATE BY 30-54% IN SKELETAL-TYPE HYPERPARATHYROIDISM BUT NOT IN OTHER TYPES OR IN CONTROLS.
SOHN HE ET AL; NIPPON NAIBUMPI GAKKAI ZASSHI 58(2) 110 (1982)
EXPTL USE: HIGH DOSES OF ORAL CALCIUM LACTATE DECR URINARY CYCLIC ADENOSINE MONOPHOSPHATE EXCRETION IN BORDERLINE CASES OF UROLITHIC AND CHEM HYPERPARATHYROIDISM.
SOHN HE ET AL; NIPPON NAIBUMPI GAKKAI ZASSHI 58(2) 110 (1982)
May be used to treat mild hypocalcemia and for maintenance therapy. /From table/
American Medical Association, Council on Drugs. AMA Drug Evaluations Annual 1994. Chicago, IL: American Medical Association, 1994., p. 2246
MEDICATION (VET): IN CALCIUM THERAPY
SRI
CALCIUM GLUCONATE & BOROGLUCONATE ARE CONSIDERED TO BE SIGNIFICANTLY LESS TOXIC THAN THE LACTATE OR THE CHLORIDE.
Humphreys, D.J. Veterinary Toxicology. 3rd ed. London, England: Bailliere Tindell, 1988., p. 28
Indicated for use as the nutritional supplement.
Both components of calcium lactate, calcium ion and lactic acid, play essential roles in the human body as a skeletal element an energy source, respectively.
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12A - Calcium
A12AA - Calcium
A12AA05 - Calcium lactate
Absorption
In order to be absorbed, calcium must be in its freely soluble form (Ca2+) or bound to a soluble organic molecule. Calcium absorption mainly occurs at the duodenum and proximal jejunum due to more acidic pH and the abundance of the calcium binding proteins. The mean calcium absorption is about 25% of calcium intake (range is 10 40%) in the small intestine, and is mediated by both passive diffusion and active transport.
Route of Elimination
Following oral administration to a human volunteer, 20 to 30% of a dose of lactic acid of up to 3000 mg was excreted via the urine during a period of 14 hours.
Volume of Distribution
The majority of calcium absorbed (99%) is stored in the skeleton and teeth for structural integrity.
Clearance
No pharmacokinetic data available.
In hepatic gluconeogenesis, lactic acid is converted to glucose. Lactic acid may be further catabolyzed in the lactic acid cycle.
RUMINAL INGESTA FROM COWS FED 2.5 L GRAIN-ALFALFA HAY MIXT PROVIDING 545 G OF SODIUM LACTATE & CALCIUM LACTATE DAILY INCUBATED WITH SODIUM LACTATE OR 17 POLY LACTIC ACID. ACETATE WAS PRIMARY END PRODUCT BUT OXIDN OF LACTATE CAUSED SYNTH OF BUTYRATE FROM ACETATE.
SATTER LD, ESDALE WJ; APPL MICROBIOL 16(5) 680 (1968)
No pharmacokinetic data available.
In aqueous environments such as the gastrointestinal (GI) tract, calcium lactate will dissociate into calcium cation and lactic acid anions, the conjugate base of lactic acid. Lactic acid is a naturally-occurring compound that serves as fuel or energy in mammals by acting as an ubiquitous intermediate in the metabolic pathways. Lactic acid diffuses through the muscles and is transported to the liver by the bloodstream to participate in gluconeogenesis.
Market Place
ABOUT THIS PAGE
54
PharmaCompass offers a list of Calcium Lactate API API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Lactate API manufacturer or Calcium Lactate API supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Lactate API manufacturer or Calcium Lactate API supplier.
PharmaCompass also assists you with knowing the Calcium Lactate API API Price utilized in the formulation of products. Calcium Lactate API API Price is not always fixed or binding as the Calcium Lactate API Price is obtained through a variety of data sources. The Calcium Lactate API Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A E-327 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E-327, including repackagers and relabelers. The FDA regulates E-327 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E-327 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of E-327 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A E-327 supplier is an individual or a company that provides E-327 active pharmaceutical ingredient (API) or E-327 finished formulations upon request. The E-327 suppliers may include E-327 API manufacturers, exporters, distributors and traders.
click here to find a list of E-327 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A E-327 DMF (Drug Master File) is a document detailing the whole manufacturing process of E-327 active pharmaceutical ingredient (API) in detail. Different forms of E-327 DMFs exist exist since differing nations have different regulations, such as E-327 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A E-327 DMF submitted to regulatory agencies in the US is known as a USDMF. E-327 USDMF includes data on E-327's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The E-327 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of E-327 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The E-327 Drug Master File in Japan (E-327 JDMF) empowers E-327 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the E-327 JDMF during the approval evaluation for pharmaceutical products. At the time of E-327 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of E-327 suppliers with JDMF on PharmaCompass.
A E-327 CEP of the European Pharmacopoeia monograph is often referred to as a E-327 Certificate of Suitability (COS). The purpose of a E-327 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of E-327 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of E-327 to their clients by showing that a E-327 CEP has been issued for it. The manufacturer submits a E-327 CEP (COS) as part of the market authorization procedure, and it takes on the role of a E-327 CEP holder for the record. Additionally, the data presented in the E-327 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the E-327 DMF.
A E-327 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. E-327 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of E-327 suppliers with CEP (COS) on PharmaCompass.
A E-327 written confirmation (E-327 WC) is an official document issued by a regulatory agency to a E-327 manufacturer, verifying that the manufacturing facility of a E-327 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting E-327 APIs or E-327 finished pharmaceutical products to another nation, regulatory agencies frequently require a E-327 WC (written confirmation) as part of the regulatory process.
click here to find a list of E-327 suppliers with Written Confirmation (WC) on PharmaCompass.
E-327 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E-327 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right E-327 GMP manufacturer or E-327 GMP API supplier for your needs.
A E-327 CoA (Certificate of Analysis) is a formal document that attests to E-327's compliance with E-327 specifications and serves as a tool for batch-level quality control.
E-327 CoA mostly includes findings from lab analyses of a specific batch. For each E-327 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E-327 may be tested according to a variety of international standards, such as European Pharmacopoeia (E-327 EP), E-327 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E-327 USP).